Our proprietary platform is unique and combines a deep knowledge of cancer biology and Immuno-Oncology, cutting-edge technologies to identify patient’s tumor neoantigens, innovative design and production of fully-synthetic, personalized DNA vaccines, a potent delivery system to maximize the immune response and the synergic effect with immune checkpoint inhibitors.